A multicenter randomized controlled trial to investigate the effect of adjustable sodium dialysis on blood pressure during dialysis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027567

Enrollment

Unknown

Registered

2019-11-18

Start date

2020-06-01

Completion date

Unknown

Last updated

2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis

Interventions

experimental group :Adjustable sodium dialysis

control group:Constant sodium dialysis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: From June 2020, we continued to collect maintenance hemodialysis patients from the Blood Purification Center of Yuedong Hospital, the third affiliated hospital of Sun Yat-sen University.

Exclusion criteria

Exclusion criteria: (1) patients with cerebrovascular accidents; (2) obvious symptoms such as headache, dizziness, nausea and vomiting before dialysis; (3) patients with systolic blood pressure >= 200 mmHg before hemodialysis; (4) patients with cardiac function III to IV; (5) Arrhythmia.

Design outcomes

Primary

Measure	Time frame
blood pressure;Interdialytic Weight Gain;	—

Countries

China

Contacts

Public ContactHongyong Liu

The Third Affiliated Hospital, Sun Yat-Sen University, Yuedong Hospital

13823850589@139.com+86 13823850589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026